iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Dynamic Advisor Solutions LLC

Dynamic Advisor Solutions LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 41.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 5,507 shares of the financial services provider’s stock after buying an additional 1,600 shares during the period. Dynamic Advisor Solutions LLC’s holdings in iShares Biotechnology ETF were worth $728,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of the business. SPC Financial Inc. grew its position in iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management grew its holdings in shares of iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the last quarter. Capital Investment Advisors LLC increased its position in iShares Biotechnology ETF by 1.0% in the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 99 shares during the period. Magnus Financial Group LLC raised its stake in iShares Biotechnology ETF by 0.8% during the 4th quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock valued at $1,714,000 after acquiring an additional 104 shares during the last quarter. Finally, Daiwa Securities Group Inc. lifted its position in iShares Biotechnology ETF by 12.0% during the 3rd quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock worth $150,000 after acquiring an additional 110 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $137.30 on Monday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The stock’s 50 day simple moving average is $136.04 and its 200-day simple moving average is $141.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.